Processa Pharmaceuticals, Inc. (PCSA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Processa Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.28x | -0.23x | -0.79x | -0.65x | -6.57x | -2.60x |
| P/B Ratio | 0.68x | 1.59x | 1.76x | 2.37x | 2.95x | 2.16x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.54x | 1.22x | 7.71x | 8.40x | 18.87x | 13.27x |
| Quick Ratio | 2.54x | 1.22x | 7.71x | 8.40x | 18.87x | 13.27x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.04x | 0.03x | 0.03x | 0.00x | 0.01x |
YoY = year-over-year change. Source: FMP..